Ronald Herbst - 07 Oct 2021 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Scientific Officer
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Ronald Herbst
Issuer symbol
PYXS
Transactions as of
07 Oct 2021
Net transactions value
$0
Form type
4
Filing time
12 Oct 2021, 19:47:26 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to buy) Award $0 +28,252 $0.000000 28,252 07 Oct 2021 Common Stock 28,252 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest 25% on the first anniversary of the October 7, 2021 grant date, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.